VarCov Co’s Collegium Pharmaceutical COLL Stock Holding History

VarCov Co’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,802	Closed	-$523K	–	393
2026 Q1	$523K	Buy	+15,802	New	+$669K	0.19%	198

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

VarCov Co's COLL Position: Q2 2026 in Review

VarCov Co sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 15,802 shares — an estimated $523K sold.

VarCov Co first reported a position in COLL in Q1 2026 and held it in 1 quarter. The position peaked at $523K in Q1 2026. 277 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

VarCov Co reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
VarCov Co sold 15,802 Collegium Pharmaceutical shares in Q2 2026, an estimated $523K.
VarCov Co first reported a position in Collegium Pharmaceutical in Q1 2026 and held it in 1 quarter.
VarCov Co's Collegium Pharmaceutical position peaked at $523K in Q1 2026.
277 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.